AMF Medical SA

Breakthrough Device designated (FDA) patch pump, to expand diabetes patient adoption and win, addressing unmet need to lower ‘therapy burden':* Capturing share through unparalleled convenience and demonstrated, patient-preferred discretion and simplicity - uniquely - using commercially available pre-filled insulin cartridges; easier, smaller and lighter;* Facilitating broader adoption through smart phone-controlled, secure, open-architecture interoperability with multiple 3rd-party Continuous Glucose Monitors and dosing algorithms, for Automated Insulin Delivery;* Expanding clinically indicated population safely with independently validated best-in-class occlusion detection and high precision;* At very significantly lower cost to manufacture and much reduced environmental impact.